Investigational Drug Details
| Drug ID: | D246 |
| Drug Name: | NRL972 |
| Synonyms: | Cholyl-lysylfluorescein |
| Type: | Chemical drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | 70697664 |
| CasNo: | -- |
| Repositioning for NAFLD: | No |
| SMILES: | S=C(NCCCC[C@H](NC(=O)CC[C@H]([C@@H]1[C@@]2([C@H]([C@H]3[C@@H]([C@@]4([C@H](C[C@H]3O)C[C@H](O)CC4)C)C[C@@H]2O)CC1)C)C)C(=O)O)Nc1cc2c(C3(OC2=O)c2c(Oc4c3ccc(O)c4)cc(O)cc2)cc1 |
| Structure: |
|
| InChiKey: | KHNJPPGHIWPDLG-DXNXUNFASA-N |
| Molecular Weight: | 926.142 |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | -- |
| Therapeutic Category: | Diagnostic contrast drug |
| Clinical Trial Progress: | Phase 2 completed (NCT00794716) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0052 | NCT00794716 | Phase 2 | Completed | No Results Available | June 2008 | June 10, 2015 | Details |
| L0339 | NCT00856869 | Phase 1/Phase 2 | Completed | No Results Available | August 2004 | March 6, 2009 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|